Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 12:28 PM ET


Company Overview of Ritter Pharmaceuticals, Inc.

Key Executives for Ritter Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Michael D. Step 16 RelationshipsChief Executive Officer and Director55
Andrew J. Ritter 16 RelationshipsFounder, President and Director32
Ira E. Ritter 16 RelationshipsCo-Founder, Executive Chairman and Chief Strategic Officer 65
Ellen F. Mochizuki No RelationshipsPrincipal Financial Officer--
AnnKatrin Petersen Jappelli M.D., MSc.No RelationshipsChief Medical Officer61

Ritter Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ira E. Ritter 16 RelationshipsRitter Pharmaceuticals, Inc.65
Michael D. Step 16 RelationshipsRitter Pharmaceuticals, Inc.55
Andrew J. Ritter 16 RelationshipsRitter Pharmaceuticals, Inc.32
Matthew W. Foehr 28 RelationshipsLigand Pharmaceuticals Incorporated42
Paul V. Maier M.B.A. 58 RelationshipsInternational Stem Cell Corporation67
View All Board Members

Ritter Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee M.B.A.Paul V. Maier58 Relationships3 Executives
Compensation Committee Matthew W. Foehr28 Relationships3 Executives
Nominating Committee Gerald T. Proehl58 Relationships3 Executives
Corporate Governance Committee Gerald T. Proehl58 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$90.0K
Compensation as of Fiscal Year 2014
Ritter Pharmaceuticals, Inc. CEO Compensation
Industry Average


Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET
Pental Ltd Announces Board Appointments
November 19, 2015 9:45 PM ET
Hipolin Ltd Announces Reconstitution of Audit, Nomination and Remuneration Committee
November 06, 2015 12:30 PM ET
Church & Dwight Co. Inc. Announces Management Changes
October 29, 2015 8:38 PM ET
SCA Appoints Anna Sävinger-Åslund as its new Senior Vice President, Group Function Human Resources, Effective from November 1, 2015
October 29, 2015 6:45 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ritter Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at